Pathway Financial Advisers’s Cabot Corp CBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-71
Closed -$5.37K 190
2025
Q3
$5.37K Buy
+71
New +$5.54K ﹤0.01% 354
2025
Q1
Sell
-70
Closed -$6.34K 194
2024
Q4
$6.34K Sell
70
-7,664
-99% -$824K ﹤0.01% 387
2024
Q3
$69 Buy
7,734
+7,665
+11,109% +$764K ﹤0.01% 409
2024
Q2
$6.33K Buy
69
+1
+1% +$97 ﹤0.01% 375
2024
Q1
$6.33K Hold
68
﹤0.01% 379
2023
Q4
$5.7K Hold
68
﹤0.01% 403
2023
Q3
$4.71K Buy
+68
New +$4.73K ﹤0.01% 420
2023
Q1
$5.15K Hold
67
﹤0.01% 434
2022
Q4
$4.47K Buy
+67
New +$4.68K ﹤0.01% 494

Other funds holding CBT

Pathway Financial Advisers's CBT Position: Q4 2025 in Review

Pathway Financial Advisers sold out of Cabot Corp (CBT) in Q4 2025, closing a stake of 71 shares — an estimated $5.37K sold.

Pathway Financial Advisers first reported a position in CBT in Q4 2022 and held it in 9 quarters. The position peaked at $6.34K in Q4 2024. 364 funds tracked by Wall St. Rank hold CBT as of Q4 2025.

  • Pathway Financial Advisers reported no remaining Cabot Corp position as of Q4 2025 after selling out during the quarter.
  • Pathway Financial Advisers sold 71 Cabot Corp shares in Q4 2025, an estimated $5.37K.
  • Pathway Financial Advisers first reported a position in Cabot Corp in Q4 2022 and held it in 9 quarters.
  • Pathway Financial Advisers's Cabot Corp position peaked at $6.34K in Q4 2024.
  • 364 funds tracked by Wall St. Rank held Cabot Corp as of Q4 2025.

Based on Pathway Financial Advisers's 13F filing for Q4 2025, filed 6 Feb 2026.